Home / Resource Library / Venetoclax Improves Quality of Life for Patients with Relapsed/Refractory Chronic Lymphocytic Leukemia

Venetoclax Improves Quality of Life for Patients with Relapsed/Refractory Chronic Lymphocytic Leukemia

Results of a phase III trial investigating venetoclax for relapsed CLL.